These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17099632)

  • 1. Metastasectomy for isolated bilateral adrenal metastases in hormone-refractory prostate cancer.
    Kohli M; Viswamitraa S; Schaefer R; Faas FH; Kumar U
    Clin Adv Hematol Oncol; 2006 Oct; 4(10):754-5; discussion 756-7. PubMed ID: 17099632
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of an adrenal mass in a patient with progressive prostate cancer reveals pheochromocytoma.
    Alikhan MA; Williams R; Udaya K; Shaefer RF; Viswamitra SC; Kohli M
    Int J Urol; 2006 Jun; 13(6):798-800. PubMed ID: 16834663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the risk of patients with biopsy Gleason score 6 to harbor a higher grade cancer.
    Gofrit ON; Zorn KC; Taxy JB; Lin S; Zagaja GP; Steinberg GD; Shalhav AL
    J Urol; 2007 Nov; 178(5):1925-8. PubMed ID: 17868725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of low prostate specific antigen on prostate cancer--a rare case report.
    Schneider HB
    Eur J Med Res; 2007 Jul; 12(7):311-3. PubMed ID: 17933704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Open adrenalectomy for adrenal metastases from lung cancer--usefulness and problem of laparoscopic adrenalectomy].
    Nakanishi S; Hori D; Maeda S; Hatayama T
    Hinyokika Kiyo; 2006 Oct; 52(10):757-60. PubMed ID: 17131861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase.
    Xie W; Nakabayashi M; Regan MM; Oh WK
    Cancer; 2007 Dec; 110(12):2709-15. PubMed ID: 17960608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic adrenalectomy for isolated adrenal metastasis from cervical squamous cell carcinoma and endometrial adenocarcinoma.
    Choi JJ; Buttrick S; Zakashansky K; Nezhat F; Chin EH
    Gynecol Oncol; 2011 Sep; 122(3):684-5. PubMed ID: 21664660
    [No Abstract]   [Full Text] [Related]  

  • 8. [Predictive value of serum PSA in detection of prostate cancer by fine needle biopsy].
    Pozharisskiĭ KM; Arzumanov AA; Kudaĭbergenova AG; Ovchinnikov IV; Leonenkov RV
    Vopr Onkol; 2008; 54(3):324-7. PubMed ID: 18652237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy.
    Cohen JK; Miller RJ; Ahmed S; Lotz MJ; Baust J
    Urology; 2008 Mar; 71(3):515-8. PubMed ID: 18342200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytology of metastatic prostate cancer following orchiectomy and antiandrogen therapy: a diagnostic challenge.
    Rapkiewicz A; Gorokhovsky R; Farcon E; Das K
    Diagn Cytopathol; 2008 Jul; 36(7):499-502. PubMed ID: 18528888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative approach in the treatment of adrenal metastasis with a real-time tracking radiotherapy in patients with hormone refractory prostate cancer.
    Sazawa A; Shinohara N; Harabayashi T; Abe T; Shirato H; Nonomura K
    Int J Urol; 2009 Apr; 16(4):410-2. PubMed ID: 19416403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robot-assisted adrenalectomy (total, partial, & metastasectomy).
    Ball MW; Allaf ME
    Urol Clin North Am; 2014 Nov; 41(4):539-47. PubMed ID: 25306165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.
    Sankin A; Tareen B; Lepor H
    Prostate Cancer Prostatic Dis; 2009; 12(2):204-8. PubMed ID: 19238170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical prostatectomy for clinical stage T3a disease.
    Freedland SJ; Partin AW; Humphreys EB; Mangold LA; Walsh PC
    Cancer; 2007 Apr; 109(7):1273-8. PubMed ID: 17315165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of patient age on biochemical recurrence rates following radical prostatectomy.
    Magheli A; Rais-Bahrami S; Humphreys EB; Peck HJ; Trock BJ; Gonzalgo ML
    J Urol; 2007 Nov; 178(5):1933-7; discussion 1937-8. PubMed ID: 17868723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radial distance of extraprostatic extension measured by an ocular micrometer is an independent predictor of prostate-specific antigen recurrence: a new proposal for the substaging of pT3a prostate cancer.
    Epstein JI
    Am J Surg Pathol; 2008 Feb; 32(2):337-8; author reply 338-40. PubMed ID: 18223339
    [No Abstract]   [Full Text] [Related]  

  • 17. Bilateral testicular metastases from prostatic carcinoma.
    Manikandan R; Nathaniel C; Reeve N; Brough RJ
    Int J Urol; 2006 Apr; 13(4):476-7. PubMed ID: 16734881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
    Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
    J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSA measurement following prostatectomy: an unexpected error.
    Descotes JL; Legeais D; Gauchez AS; Long JA; Rambeaud JJ
    Anticancer Res; 2007; 27(2):1149-50. PubMed ID: 17465255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solitary adrenal metastatic lesion in a patient with a history of prostate cancer.
    Barrisford GW; Sartor O; Richie JP
    Clin Genitourin Cancer; 2009 Jan; 7(1):64-6. PubMed ID: 19213672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.